Phibro Animal Health (NASDAQ:PAHC) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Phibro Animal Health (NASDAQ:PAHC) posted its quarterly earnings data on Wednesday. The company reported $0.79 earnings per share for the quarter, topping the consensus estimate of $0.78 by $0.01, FiscalAI reports. The firm had revenue of $386.77 million during the quarter, compared to analyst estimates of $382.42 million. Phibro Animal Health had a return on equity of 37.86% and a net margin of 6.57%.

Phibro Animal Health Stock Up 4.7%

Shares of NASDAQ PAHC traded up $1.78 during trading on Wednesday, hitting $39.43. 266,659 shares of the company traded hands, compared to its average volume of 281,937. The firm has a market capitalization of $1.60 billion, a price-to-earnings ratio of 16.16 and a beta of 0.42. The business’s fifty day moving average is $37.16 and its 200 day moving average is $41.09. The company has a debt-to-equity ratio of 1.84, a quick ratio of 1.27 and a current ratio of 2.96. Phibro Animal Health has a fifty-two week low of $28.25 and a fifty-two week high of $60.08.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 16th. Stockholders of record on Wednesday, November 25th will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, November 25th. This represents a $0.48 annualized dividend and a dividend yield of 1.2%. Phibro Animal Health’s dividend payout ratio is currently 19.67%.

Analyst Upgrades and Downgrades

PAHC has been the subject of several recent analyst reports. Zacks Research raised Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research note on Friday, September 18th. Weiss Ratings raised Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $47.67.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company’s products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.